Is there a role for induction therapy for locally advanced bladder cancer?
- 1 June 1987
- Vol. 29 (6) , 577-583
- https://doi.org/10.1016/0090-4295(87)90095-1
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Cis‐platin and Methotrexate in the Treatment of Transitional Cell Carcinoma of the Urinary TractBritish Journal of Urology, 1985
- Methotrexate in the Treatment of Metastatic and Recurrent Primary Transitional Cell CarcinomaJournal of Urology, 1984
- Phase II Trial of Sequentially Administered Cisplatin, Cyclophosphamide and Doxorubicin for Urothelial Tract TumorsJournal of Urology, 1983
- A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A national bladder cancer collaborative group a studyCancer, 1983
- Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinomaAmerican Journal of Clinical Oncology, 1983
- Phase II trial of vinblastine sulfate for metastatic urothelial tract tumorsCancer, 1982
- Methotrexate: An active drug in bladder cancerCancer, 1981
- Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancerCancer, 1981
- The Treatment of Advanced Bladder Cancer with MethotrexateBritish Journal of Urology, 1977
- Adriamycin in advanced urinary tract cancer.Experience in 42 patients and review of the literatureCancer, 1977